In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin.

Cefodizime (HR221) is a new alpha-methoxyimino cephalosporin developed by Hoechst-Roussel with a reported serum half-life of over 2 h. In vitro susceptibility studies showed that the cefodizime spectrum includes all those Enterobacteriaceae, staphylococci, Streptococcus spp., Haemophilus spp., and N...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Jones, R N, Barry, A L, Thornsberry, C, Wilson, H W
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1981
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181795/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6275785/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.20.6.760
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!